Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Expanded Disability Status Scale")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 46

  • Page / 2
Export

Selection :

  • and

Non-esterified fatty acids in blood cell membranes from patients with multiple sclerosisHON, Gloudina M; HASSAN, Mogamat S; RENSBURG, Susan Janse Van et al.European journal of lipid science and technology (Print). 2012, Vol 114, Num 7, pp 703-709, issn 1438-7697, 7 p.Article

Assessing changes in relapse rates in multiple sclerosisINUSAH, Seidu; SORMANI, Maria P; COFIELD, Stacey S et al.Multiple sclerosis. 2010, Vol 16, Num 12, pp 1414-1421, issn 1352-4585, 8 p.Article

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosisNOS, Carlos; SASTRE-GARRIGA, Jaume; BORRAS, Cecilia et al.Multiple sclerosis. 2004, Vol 10, Num 4, pp 413-416, issn 1352-4585, 4 p.Article

Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS) : average walking speed is a more constant parameterALBRECHT, H; WÖTZEL, C; ERASMUS, L. P et al.Multiple sclerosis. 2001, Vol 7, Num 2, pp 105-109, issn 1352-4585Article

Benign multiple sclerosis: a need for a consensusGLAD, S. B; AARSETH, J. H; NYLAND, H et al.Acta neurologica scandinavica. 2010, Vol 122, pp 44-50, issn 0001-6314, 7 p., SUP190Conference Paper

MS Functional Composite : Relation to disease phenotype and disability strataKALKERS, N. F; DE GROOT, V; LAZERON, R. H. C et al.Neurology. 2000, Vol 54, Num 6, pp 1233-1239, issn 0028-3878Article

Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosisCHO, Joong-Yang; HONG, Keun-Sik; WOOJUN KIM et al.Multiple sclerosis. 2014, Vol 20, Num 9, pp 1217-1223, issn 1352-4585, 7 p.Article

Predicting the course of relapsing-remitting MS using longitudinal disability curvesACHIRON, Anat.Journal of neurology. Supplement. 2004, Vol 251, Num 5, pp V.65-V.68, issn 0939-1517Article

Inter- and intraratar scoring agreement using grades 1.0 to 3.5 of the Kurtzke expanded disability status scale (EDSS)GOOKIN, D. E; COOKFAIR, D; WENDE, K et al.Neurology. 1992, Vol 42, Num 4, pp 859-863, issn 0028-3878Article

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisFREEDMAN, M. S; METZIG, C; FIRE, E et al.Multiple sclerosis. 2012, Vol 18, Num 7, pp 966-973, issn 1352-4585, 8 p.Article

Validity of patient-derived disability and clinical data in multiple sclerosisINGRAM, G; COLLEY, E; BEN-SHLOMO, Y et al.Multiple sclerosis. 2010, Vol 16, Num 4, pp 472-479, issn 1352-4585, 8 p.Article

A voxel-based morphometry study of disease severity correlates in relapsing- remitting multiple sclerosisPRINSTER, A; QUARANTELLI, M; LANZILLO, R et al.Multiple sclerosis. 2010, Vol 16, Num 1, pp 45-54, issn 1352-4585, 10 p.Article

2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?BIGI, Sandra; MARRIE, Ruth A; VERHEY, Leonard et al.Multiple sclerosis. 2013, Vol 19, Num 10, pp 1359-1362, issn 1352-4585, 4 p.Article

Disease progression in multiple sclerosis: combining physicians' and patients' perspectives?KRAGT, J. J; NIELSEN, J. M; VAN DER LINDEN, Fah et al.Multiple sclerosis. 2011, Vol 17, Num 2, pp 234-240, issn 1352-4585, 7 p.Article

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the I5-year analysis of the US prospective open-label study of glatiramer acetateFORD, C; GOODMAN, A. D; PRUITT, A et al.Multiple sclerosis. 2010, Vol 16, Num 3, pp 342-350, issn 1352-4585, 9 p.Article

The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosisMOHAMMAD REZA MOTAMED; NAJIMI, Neda; FERESHTEHNEJAD, Seyed-Mohammad et al.Clinical neurology and neurosurgery. 2007, Vol 109, Num 4, pp 344-349, issn 0303-8467, 6 p.Article

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosisPATZOLD, T; SCHWENGELBECK, M; OSSEGE, L.-M et al.Acta neurologica scandinavica. 2002, Vol 105, Num 3, pp 164-168, issn 0001-6314Article

Prognostic indicators for long-term disability in multiple sclerosis patientsDAMASCENO, Alfredo; VON GLEHN, Felipe; OTAVIO BRANDAO, Carlos et al.Journal of the neurological sciences. 2013, Vol 324, Num 1-2, pp 29-33, issn 0022-510X, 5 p.Article

Increased disability and MRI lesions after discontinuation of IFN-β-1a in secondary progressive MSWU, X; DASTIDAR, P; KUUSISTO, H et al.Acta neurologica scandinavica. 2005, Vol 112, Num 4, pp 242-247, issn 0001-6314, 6 p.Article

Utilization of the multiple sclerosis functional composite in follow-up : Relationship to disease phenotype, disability and treatment strategiesOZAKBAS, Serkan; ORMECI, Burcu; IDIMAN, Egemen et al.Journal of the neurological sciences. 2005, Vol 232, Num 1-2, pp 65-69, issn 0022-510X, 5 p.Article

Scales for rating impairment in multiple sclerosis: a critiqueWILLOUGHBY, E. W; PATY, D. W.Neurology. 1988, Vol 38, Num 11, pp 1793-1798, issn 0028-3878Article

Quality of life in patients with multiple sclerosis: The impact of fatigue and depressionJANARDHAN, Vallabh; BAKSHI, Rohit.Journal of the neurological sciences. 2002, Vol 205, Num 1, pp 51-58, issn 0022-510X, 8 p.Article

Comparing efficacy and side effects of a weekly intramuscular biogeneric/biosimilar interferon beta-1a with Avonex in relapsing remitting multiple sclerosis: A double blind randomized clinical trialNAFISSI, Shahriar; AZIMI, Amirreza; AMINI-HARANDI, Ali et al.Clinical neurology and neurosurgery (Dutch-Flemish ed.). 2012, Vol 114, Num 7, pp 986-989, issn 0303-8467, 4 p.Article

Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MSBOSMA, Lvae; KRAGT, J. J; POLMAN, C. H et al.Multiple sclerosis. 2013, Vol 19, Num 3, pp 326-333, issn 1352-4585, 8 p.Article

The impact of intensity variations in TI-hypointense lesions on clinical correlations in multiple sclerosisTAM, R. C; TRABOULSEE, A; RIDDEHOUGH, A et al.Multiple sclerosis. 2011, Vol 17, Num 8, pp 949-957, issn 1352-4585, 9 p.Article

  • Page / 2